What Is XDNA?
One ticker, 50 companies
The ETF has been designed to provide investors with exposure to the performance of an index, selected at the discretion of BlackRock, that is composed of companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. The current index for the ETF is the NYSE FactSet Global Genomics and Immuno Biopharma Index.
IssuerBMO Global Asset Management
Inception dateApril 26, 2022
ExchangeToronto Stock Exchange
CurrencyCAD
Risk ratingHigh
Management fee0.39%
Set it, forget it, let compounding do the heavy lifting. 💪